Atazanavir (Reyataz)

Published June 23, 2003; Updated October 2016
Susa Coffey, MD
http://hivinsite.ucsf.edu/InSite?page=ar-03-07
Selected Reference
5. Molina JM, Andrade-Villanueva J, Echevarria J, et al; CASTLE Study Team. Once-daily atazanavir/ritonavir versus twice-daily lopinavir/ritonavir, each in combination with tenofovir and emtricitabine, for management of antiretroviral-naive HIV-1-infected patients: 48 week efficacy and safety results of the CASTLE study. Lancet. 2008 Aug 23;372(9639):646-55.